Cost-Related medication nonadherence and cost-saving behaviors among patients with glaucoma before and after the implementation of medicare part D

JAMA Ophthalmology

Volumn 133, Issue 9, 2015, Pages 985-996

  Blumberg, Dana M ^a   Prager, Alisa J ^b   Liebmann, Jeffrey M ^a   Cioffi, George A ^a   De Moraes, C Gustavo ^a  

^a Edward S Harkness Eye Institute   (United States)

^b College of Physi and Surg ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG; ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; COST CONTROL; CROSS-SECTIONAL STUDY; DRUG COST; EYE CARE; FEMALE; GLAUCOMA; HEALTH CARE PLANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MEDICATION COMPLIANCE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; SELF REPORT; AGED; CONSUMER ATTITUDE; DRUG UTILIZATION; ECONOMICS; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AGED; ANTIHYPERTENSIVE AGENTS; CONSUMER BEHAVIOR; COST SAVINGS; CROSS-SECTIONAL STUDIES; DRUG COSTS; DRUG UTILIZATION; FEMALE; GLAUCOMA; HEALTH PLAN IMPLEMENTATION; HUMANS; MALE; MEDICARE PART D; MEDICATION ADHERENCE; UNITED STATES;

EID: 84941312566     PISSN: 21686165     EISSN: 21686173     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2015.1671     Document Type: Article

References (37)

1. Sleath B, Robin AL, Covert D, Byrd JE, Tudor G, Svarstad B. Patient-reported behavior and problems in using glaucoma medications. Ophthalmology. 2006;113(3):431-436.
2. Tsai JC. A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology. 2009;116(11)(suppl):S30-S36.
3. Friedman DS, Hahn SR, Gelb L, et al. Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study. Ophthalmology. 2008;115(8):1320-1327, 1327. e1-1327. e3.
4. Rossi GC, Pasinetti GM, Scudeller L, Radaelli R, Bianchi PE. Do adherence rates and glaucomatous visual field progression correlate? Eur J Ophthalmol. 2011;21(4):410-414.
5. Sleath B, Blalock S, Covert D, et al. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity. Ophthalmology. 2011;118(12):2398-2402.
6. Briesacher BA, Zhao Y, Madden JM, et al. Medicare part D and changes in prescription drug use and cost burden: national estimates for the Medicare population, 2000 to 2007. Med Care. 2011;49(9):834-841.
7. Adler GS. A profile of the Medicare Current Beneficiary Survey. Health Care Financ Rev. 1994;15 (4):153-163.
8. Adler GS. Medicare beneficiaries rate their medical care: new data from the MCBS (Medicare Current Beneficiary Survey). Health Care Financ Rev. 1995;16(4):175-187.
9. LawtonMP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179-186.
10. Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: findings from a 2003 national survey. Health Aff (Millwood). 2005;(suppl web exclusives):W5-152-W5-166.
11. Pierre-JacquesM, Safran DG, Zhang F, et al. Reliability of new measures of cost-related medication nonadherence. Med Care. 2008;46(4): 444-448.
12. Hidalgo B, Goodman M. Multivariate or multivariable regression? Am J Public Health. 2013; 103(1):39-40.
13. Congdon N, O'Colmain B, Klaver CC, et al; Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122(4): 477-485.
14. Frank RG, Newhouse JP. Should drug prices be negotiated under part D of Medicare? and if so, how? Health Aff (Millwood). 2008;27(1):33-43.
15. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, HusseinM; Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002; 120(10):1268-1279.
16. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701-713.
17. Donohue JM. The impact and evolution of Medicare Part D. NEngl J Med. 2014;371(8):693-695.
18. Blancato RB. Why Medicare part D worked when many said it wouldn't. http://www. huffingtonpost. com/robert-b-blancato/why-medicare-part-d-worke-b-4268352. html. Published November 13, 2013. Accessed December 28, 2014.
19. Levine DA, Morgenstern LB, Langa KM, Piette JD, Rogers MAM, Karve SJ. Recent trends in cost-related medication nonadherence among stroke survivors in the United States. Ann Neurol. 2013;73(2):180-188.
20. Madden JM, Graves AJ, Zhang F, et al. Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA. 2008;299(16):1922-1928.
21. Kennedy J, Tuleu I, Mackay K. Unfilled prescriptions of medicare beneficiaries: prevalence, reasons, and types of medicines prescribed. J Manag Care Pharm. 2008;14(6):553-560.
22. Zivin K, Madden JM, Graves AJ, Zhang F, Soumerai SB. Cost-related medication nonadherence among beneficiaries with depression following Medicare Part D. Am J Geriatr Psychiatry. 2009;17(12):1068-1076.
23. Kelloway JS, Wyatt RA, Adlis SA. Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch Intern Med. 1994; 154(12):1349-1352.
24. Lacey J, Cate H, Broadway DC. Barriers to adherence with glaucoma medications: a qualitative research study. Eye (Lond). 2009;23 (4):924-932.
25. Schwartz GF, Quigley HA. Adherence and persistence with glaucoma therapy. Surv Ophthalmol. 2008;53(suppl 1):S57-S68.
26. Gascón JJ, Sánchez-Ortuño M, Llor B, Skidmore D, Saturno PJ; Treatment Compliance in Hypertension Study Group. Why hypertensive patients do not comply with the treatment: results from a qualitative study. FamPract. 2004;21(2):125-130.
27. Vincze G, Barner JC, Lopez D. Factors associated with adherence to self-monitoring of blood glucose among persons with diabetes. Diabetes Educ. 2004;30(1):112-125.
28. Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: ameta-analytic review of the Necessity-Concerns Framework. PLoS One. 2013;8(12):e80633.
29. Kennedy JJ, Maciejewski M, Liu D, Blodgett E. Cost-related nonadherence in the Medicare program: the impact of Part D. Med Care. 2011;49 (5):522-526.
30. Madden JM, Graves AJ, Ross-Degnan D, Briesacher BA, Soumerai SB. Cost-related medication nonadherence after implementation of Medicare Part D, 2006-2007. JAMA. 2009;302 (16):1755-1756.
31. Billimek J, Malik S, Sorkin DH, et al. Understanding disparities in lipid management among patients with type 2 diabetes: gender differences in medication nonadherence after treatment intensification. Womens Health Issues. 2015;25(1):6-12.
32. Piette JD, Heisler M, Wagner TH. Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk. Am J Public Health. 2004;94(10):1782-1787.
33. Nordstrom BL, Friedman DS, Mozaffari E, Quigley HA, Walker AM. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol. 2005;140(4):598-606.
34. Friedman DS, Okeke CO, Jampel HD, et al. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma. Ophthalmology. 2009;116(6):1097-1105.
35. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028-3035.
36. Kass MA, Gordon M, Meltzer DW. Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy? Am J Ophthalmol. 1986;101(5):524-530.
37. Jonk Y, O'Connor H, Schult T, et al. Using the Medicare Current Beneficiary Survey to conduct research on Medicare-eligible veterans. J Rehabil Res Dev. 2010;47(8):797-813.